Real World Study
The Growing Demand for Real-World Evidence
Mees Medical's drug safety and pharmacovigilance team supports clinical trials and post-market safety monitoring for pharmaceutical and medical devices, providing independent and comprehensive services throughout the product lifecycle for our clients.
What sets us apart is our employees: highly qualified drug safety scientists and skilled medical professionals who have deep expertise in patient management, specific pharmacovigilance services, and regulatory affairs, with extensive experience in drug safety management.
We Can Assist You With:
-
Characterizing the natural history and progression of disease (e.g., incidence, prevalence, standards of care)
-
Identifying unmet clinical and human needs by describing the disease burden
-
Collecting data on rare disease populations
-
Quantifying real-world product-specific and/or comparative safety, efficacy, compliance, and other outcomes
-
Evaluating specific treatment patterns, quantifying related care costs, and populating health economics models
In-Depth Data Insights
We focus on your research questions and provide the best solutions that include a variety of real-world data sources and datasets. Our integrated team of health economists, epidemiologists, biostatisticians, and clinicians rigorously evaluates available databases to determine which ones provide the best information to meet your research needs. We have in-depth knowledge and experience with data sources from over 20 countries (including North America and Europe) as well as other regions such as Brazil, Japan, South Korea, China, Australia, and Taiwan. We are familiar with and can analyze large claims databases, electronic medical records, and combinations of these and other data sources.
We focus on your research questions and provide the best solutions that include a variety of real-world data sources and datasets. Our integrated team of health economists, epidemiologists, biostatisticians, and clinicians rigorously evaluates available databases to determine which ones provide the best information to meet your research needs. We have in-depth knowledge and experience with data sources from over 20 countries (including North America and Europe) as well as other regions such as Brazil, Japan, South Korea, China, Australia, and Taiwan. We are familiar with and can analyze large claims databases, electronic medical records, and combinations of these and other data sources.
In-Depth Collaboration with Professional Institutions, Associations, Societies, and KOLs
Achieving optimal market access and effective commercialization requires customized research design, in-depth expertise, and a network of relationships with national KOLs. Our understanding of the post-market environment, combined with over a decade of clinical research experience, translates into unique capabilities to provide tailored and effective research designs that meet specific goals, market demands, and product regulatory requirements. Additionally, our operating model is customized based on expert opinions from medical, clinical, project management, regulatory, healthcare, and epidemiology functions to meet the project-specific goals and stakeholder expectations.
Excellence in Research Design and Execution
- Extensive experience - Focused on real-world research design, operations, monitoring, and outcomes teams, 15 key clinical research areas, 200+ collaborative research sites, 500+ long-term collaborating researchers, 70,000+ chief physician members, and 2 million clinical physician resources
- Professional research team - Achieving significantly better research initiation and patient recruitment times compared to industry benchmarks when working under early-stage collaboration models
- Therapeutic area experts - Ability to handle a wide range of indications and leverage our network of clinicians and national operations professionals
- Through technology and collaborative innovation - Fully leveraging artificial intelligence and big data technology, as well as the characteristics of real-world research, significantly reducing research costs, improving operational efficiency, and ensuring high-quality research outcomes
